Published in Biotechniques on February 01, 1997
Patterns of transcription of human cytomegalovirus in permissively infected cells. J Virol (1980) 3.08
Comparative inactivation of viruses by chlorine. Appl Environ Microbiol (1980) 2.04
Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DNA. Clin Chem (1999) 1.77
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
Detection of herpesvirus type 6 by polymerase chain reaction in blood donors: random tests and prospective longitudinal studies. Br J Haematol (1994) 1.53
Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26. Biochemistry (1988) 1.38
Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation. Transplantation (2001) 1.38
Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of beta-actin transcripts as quantitative reference. Clin Chem (1999) 1.35
Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens. J Clin Microbiol (1994) 1.29
LightCycler technology for the quantitation of bcr/abl fusion transcripts. Cancer Res (1999) 1.27
Detection of human cytomegalovirus DNA by real-time quantitative PCR. J Clin Microbiol (2000) 1.24
Impalement injuries to the thorax as a result of motor vehicle accidents. Ann Thorac Surg (1987) 1.24
Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood (1994) 1.20
Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR. Mol Cell Probes (2002) 1.20
Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells. Oncogene (2006) 1.08
Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome. Leukemia (2011) 0.99
Platypnea-orthodeoxia as a cause of unexplained hypoxemia in an 82-yr-old female. Cathet Cardiovasc Diagn (1990) 0.95
Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood (1994) 0.94
Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis. Ann Thorac Surg (2000) 0.94
A potential role for human herpesvirus type 6 in nervous system disease. J Neuroimmunol (1994) 0.93
Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysis. Cancer Res (1999) 0.92
Enhanced p73 expression during differentiation and complex p73 isoforms in myeloid leukemia. Biochem Biophys Res Commun (2000) 0.92
Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells. Cancer Res (1991) 0.92
Regulation of the nuclear proteasome activity in myelomonocytic human leukemia cells after adriamycin treatment. Blood (2001) 0.89
A genetic assessment of parentage in a natural population of dollar sunfish (Lepomis marginatus) based on microsatellite markers. Mol Ecol (2002) 0.89
Opioid receptor density changes in Alzheimer amygdala and putamen. Brain Res (1993) 0.89
Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation. Transplantation (1994) 0.87
Identification of human cytomegalovirus variants by analysis of single strand conformation polymorphism and DNA sequencing of the envelope glycoprotein B gene region-distribution frequency in liver transplant recipients. J Virol Methods (1999) 0.87
Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques. Leukemia (1993) 0.87
Human herpesvirus type 7 in blood donors: detection by the polymerase chain reaction. J Med Virol (1995) 0.86
Subcellular distribution of the alpha and beta topoisomerase II-DNA complexes stabilized by VM-26. Biochem Pharmacol (1994) 0.84
Elevated p21 mRNA level in skeletal muscle of DMD patients and mdx mice indicates either an exhausted satellite cell pool or a higher p21 expression in dystrophin-deficient cells per se. J Mol Med (Berl) (2000) 0.84
Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction. Cancer Res (2001) 0.84
Association of cytokeratin p39 with DNA in intact Novikoff hepatoma cells. Proc Natl Acad Sci U S A (1984) 0.83
Hepatocytes are permissive for human cytomegalovirus infection in human liver cell culture and In vivo. J Infect Dis (1999) 0.83
Phase I trial of gemcitabine (Gemzar), 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer. Anticancer Drugs (1999) 0.83
Applicability of an absolute quantitative procedure to monitor intra-individual bcr/abl transcript kinetics in clinical samples from chronic myelogenous leukemia patients. Int J Cancer (2000) 0.83
Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approach. Leukemia (2000) 0.83
Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias. Br J Haematol (2001) 0.82
Zygosity at the major histocompatibility class IIB locus predicts susceptibility to Renibacterium salmoninarum in Atlantic salmon (Salmo salar L.). Anim Genet (2007) 0.82
A translocated mitochondrial cytochrome b pseudogene in voles (Rodentia: Microtus) J Mol Evol (1999) 0.82
Extramedullary manifestation of a donor-derived acute myeloid leukemia in a liver transplant patient. Leukemia (2004) 0.82
Thoracic aortic injury. A ten-year experience. Arch Surg (1984) 0.81
Cross-linking of Novikoff ascites hepatoma cytokeratin filaments. Biochemistry (1985) 0.81
Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab. Exp Hematol (2001) 0.80
Molecular characterization of illegitimate TCR delta gene rearrangements in acute myeloid leukaemia. Br J Haematol (1994) 0.80
Treatment with ganciclovir and Ig for acute Epstein-Barr virus infection after allogeneic bone marrow transplantation. Blood (1993) 0.79
Altered DNA topoisomerase II in multidrug resistance. Cytotechnology (1993) 0.78
Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells. Cancer Res (1989) 0.78
Novel T-cell receptor delta gene rearrangement involving a recombining element located 2.6 kb 3' from the Vdelta2 gene segment. Leuk Res (2001) 0.78
Influence of DNA polymerases on quantitative PCR results using TaqMan probe format in the LightCycler instrument. Mol Cell Probes (2000) 0.78
Bronchogenic cyst presenting subsequent to intrapleural rupture. West J Med (1981) 0.78
Soluble interleukin 2 receptors in patients after bone marrow transplantation. Bone Marrow Transplant (1990) 0.78
Increased ATP requirement for activity of and complex formation by DNA topoisomerase II from human leukemic CCRF-CEM cells selected for resistance to teniposide. Cancer Commun (1989) 0.78
Nuclear matrix antigens in azo dye-induced primary rat hepatomas. Cancer Res (1984) 0.78
Differential expression of the oncoproteins c-myc and c-myb in human lymphoproliferative disorders. Eur J Cancer (1990) 0.78
Remote asynergy detected by biplane transesophageal echocardiography during myocardial revascularization without cardiopulmonary bypass. Anesth Analg (1991) 0.78
Simultaneous absolute quantification of target and control templates by real-time fluorescence reverse transcription-PCR using 4-(4'-dimethylaminophenylazo)benzoic acid as a dark quencher dye. Clin Chem (2001) 0.77
Quantifying male-biased dispersal among social groups in the collared peccary (Pecari tajacu) using analyses based on mtDNA variation. Heredity (Edinb) (2010) 0.77
Decreased resistance to N,N-dimethylated anthracyclines in multidrug-resistant Friend erythroleukemia cells. Cancer Chemother Pharmacol (1993) 0.77
PCR-SSCP: nonradioisotopic detection with biotinylated primers and streptavidin-alkaline phosphatase conjugate. Biotechniques (1995) 0.77
Trinucleotide repeat polymorphism at the alpha-enolase/tau-crystallin locus in ducks. Anim Genet (1996) 0.77
Molecular alterations in a patient with Turcot's syndrome. Br J Cancer (1993) 0.77
Accuracy and precision of methods to estimate the number of parents contributing to a half-sib progeny array. J Hered (2001) 0.76
Induction of differentiation in Friend-erythroleukemia cells by aclacinomycin A: early transient decrease in c-myc and c-myb mRNA levels. Leukemia (1992) 0.76
Bullet fragment venous embolus to the heart: case report. J Trauma (1991) 0.76
Detection of p53 mutations using nonradioactive SSCP analysis: p53 is not frequently mutated in myelodysplastic syndromes (MDS). Ann Hematol (1993) 0.76
Routine applications of DNA fingerprinting with the oligonucleotide probe (CAC)5/(GTG)5. Clin Genet (1991) 0.76
Comparative evaluation of the human whole blood and human peripheral blood monocyte tests for pyrogens. Int J Pharm (2003) 0.75
[Risks and prevention in orthotopic liver transplantation and persistent infection with hepatitis type B and type delta viruses]. Z Arztl Fortbild (Jena) (1992) 0.75
Biological evaluation of recombinant human erythropoietin in pharmaceutical products. Braz J Med Biol Res (2003) 0.75
Minimal impact of CMV infection on long-term survival after liver transplantation. Transplant Proc (2002) 0.75
Immunocytochemical detection of p21ras expression in fresh human leukaemic cells and cell lines. Blut (1989) 0.75
Is preemptive therapy for CMV infection following liver transplantation superior to symptom-triggered treatment? Transplant Proc (2001) 0.75
Incidence and therapy of cytomegalovirus disease after liver transplantation. Transplant Proc (1993) 0.75
Primary human herpesvirus 6 infection in an adult. N Engl J Med (1993) 0.75
Septal wall motion. Its significance on outcome of left ventricular scar resection. Arch Surg (1980) 0.75
[Lung metastases of colorectal tumors: clinical background and development of care supply]. Radiologe (2004) 0.75
[Recommendations for the diagnosis and therapy of cytomegalovirus infection after stem-cell transplantation. The Research Alliance on the Complications of Organ Transplantation due to Herpes Viruses]. Dtsch Med Wochenschr (1999) 0.75
Preemptive therapy in CMV-antigen positive patients after liver transplantation--a prospective trial. Ann Transplant (1999) 0.75
[HIV infection caused by needle injury]. Dtsch Med Wochenschr (1987) 0.75
[Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology]. Dtsch Med Wochenschr (2000) 0.75
[Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation]. Dtsch Med Wochenschr (2001) 0.75
[Orthotopic liver transplantation in hepatic cirrhosis: on the problem of infection of the transplant with persistent hepatitis viruses]. Z Gastroenterol (1992) 0.75
Cytomegalovirus disease after liver transplantation: diagnostics and therapy. Transplant Proc (1993) 0.75
Arteriovenous fistula in arterial reconstruction of the ischemic limb. Arch Surg (1983) 0.75
Epstein-Barr virus DNA quantitation assessed by a real-time polymerase chain reaction in a case of Burkitt's lymphoma. Leuk Lymphoma (2001) 0.75
Characterization of monoclonal antibodies to novikoff hepatoma cytokeratin antigen p39. Cancer Res (1984) 0.75